A tool to help cancer survivors plan for parenthood
Roadmap to Parenthood: Testing the Efficacy of a Decision Aid and Planning Tool for Family Building After Cancer
This study tests a new online tool to help women who have survived cancer make informed choices about starting a family after treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 256 (estimated) |
| Ages | 18 Years to 45 Years |
| Sex | Female |
| Sponsor | Stanford University Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy, radiation |
| Locations | 1 site (Palo Alto, California) |
| Trial ID | NCT06050135 on ClinicalTrials.gov |
What this trial studies
This study tests a web-based decision aid and planning tool designed to support individuals assigned female at birth who have a history of cancer in making informed decisions about family building after treatment. Participants will be randomly assigned to receive either the decision aid or an informational booklet. The goal is to evaluate the effectiveness of this intervention in improving quality of life and parenthood status among cancer survivors. The study aims to provide tailored support to those uncertain about their family planning options post-cancer.
Who should consider this trial
Good fit: Ideal candidates are individuals assigned female at birth, aged 18 to 45, who have completed cancer treatment and are considering future childbearing.
Not a fit: Patients currently undergoing cancer treatment or those with significant disabilities that hinder study participation may not benefit from this study.
Why it matters
Potential benefit: If successful, this tool could empower cancer survivors to make informed decisions about starting a family, potentially improving their quality of life.
How similar studies have performed: Other studies have shown success with decision aids in healthcare, suggesting that this approach may be effective, though this specific intervention is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Assigned female at birth * Aged 18 to 45 years old * Understands verbal and written English * History of a cancer diagnosis. * Completed cancer treatment(s) with known or uncertain gonadotoxic effects (e.g., systemic chemotherapy, surgery or radiation affecting reproductive organs or hormone regulation, stem cell or bone marrow transplant, and/or immunotherapy) * Interested in having a future child (or more children) or uncertain about family building plans * Access to the Internet and use of a computer, tablet, or smartphone * Ability to understand and the willingness to personally sign the written IRB-approved informed consent document Exclusion Criteria: * Currently undergoing cancer treatment excluding long term adjuvant or maintenance therapies, such as tamoxifen * Significant physical or mental disability that prevents completion of study activities
Where this trial is running
Palo Alto, California
- Stanford Universtiy — Palo Alto, California, United States (Recruiting)
Study contacts
- Principal investigator: Catherine Benedict, PhD — Stanford University
- Study coordinator: Catherine Benedict, PhD
- Email: cbenedict@stanford.edu
- Phone: 650-498-5566
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.